4th Tecan Symposium enjoys Chinese success
Publication date: 17 November 2011
Author: kdm communications limited
Tagged with: Tecan
Tecan recently hosted the fourth annual Tecan Symposium, welcoming leading genomics, proteomics and biobanking experts from around the globe to discuss this year’s topic; Translational Medicine: From bench to bedside and back. Held outside of Europe for the first time, the 2011 Tecan Symposium was in Shanghai, China, reflecting Tecan’s strong commitment to the Asian market and the growing importance of China as a major center for genomics and clinical research.
Delegates at the Tecan Symposium 2011
The two-day event was divided into four topics – current trends in translational research, clinical aspects of translational medicine, the growing importance of biobanking and the impact of technology on translational science – and explored a wide range of current hot topics in this fast-growing area of life science research.
The high quality program for this year’s event was opened by Professor Huanming Yang, President of China’s very own ‘genome factory’, the Beijing Genomics Institute (BGI). A succession of enlightening presentations then charted the contributions that genomics and, more recently, proteomics have played in enhancing our understanding of the world around us, and how these breakthroughs are being applied to global health issues.
The second day’s program concentrated on the technologies behind the science, looking at why “biobanks are more than just a place to store freezers,” the huge tasks that face the exciting global initiatives now being undertaken and what we can learn from the mummified remains of our ancient past. Fittingly, the Symposium’s final presentation was by Dr Colin Campbell from the University of Edinburgh, who discussed an exciting collaborative project first conceived during a chance meeting at the very first Tecan Symposium in Zurich.
Alongside the scientific content, Tecan’s local representatives – Tecan (Shanghai) Trading Company Ltd – arranged a number of social events for delegates, including a river cruise to provide a more relaxed environment to discuss the day’s topics, and a visit to a traditional Chinese tea house to celebrate the rich cultural heritage of Shanghai itself. Overall, the 4th Tecan Symposium was hailed a great success, once again highlighting the innovation-driven, customer-focused approach that has made Tecan a leading provider within the life sciences sector.
To find out more about the Tecan Symposium, visit www.tecan.com/symposium
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Fast plasma sample cleanup with new Phree Phospholipid Removal Plates (21 May 2012)
- Two overall winners announced at prestigious national award ceremony in London’s Science Museum (18 May 2012)
- New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine (18 May 2012)
- NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN) (18 May 2012)
- GSK statement on tender offer to acquire Human Genome Sciences (18 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content